A novel, investigational NaV1.8 sodium channel blocker known as VX-548 reduced acute pain after abdominoplasty or bunionectomy at the highest dose, but not at lower doses, two phase II trials showed.
Treatment of neuropathic pain can be achieved with drugs that block voltage-gated sodium channels. However, at present, there are no subtype-specific blockers that discriminate between the different ...
Mutant Brown-Norway-Katholiek (muBN-Ka) rats are capable of producing kininogens in the liver, but cannot release them into the bloodstream, because of the point mutation of Ala163 to Thr in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results